Shaoxia Yu

955 total citations
22 papers, 660 citations indexed

About

Shaoxia Yu is a scholar working on Molecular Biology, Mechanical Engineering and Spectroscopy. According to data from OpenAlex, Shaoxia Yu has authored 22 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Mechanical Engineering and 4 papers in Spectroscopy. Recurrent topics in Shaoxia Yu's work include Drug Transport and Resistance Mechanisms (3 papers), Analytical Chemistry and Chromatography (3 papers) and Microstructure and mechanical properties (3 papers). Shaoxia Yu is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Analytical Chemistry and Chromatography (3 papers) and Microstructure and mechanical properties (3 papers). Shaoxia Yu collaborates with scholars based in United States, China and Japan. Shaoxia Yu's co-authors include Jing‐Tao Wu, Elizabeth A. Crawford, Brian Musselman, Philip W. Le Quesne, Susan R. Norris, Georg Jander, Vijay Joshi, Lily Li, Robert L. Last and Shelly Li and has published in prestigious journals such as Analytical Chemistry, Neurology and Cancer Research.

In The Last Decade

Shaoxia Yu

21 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoxia Yu United States 11 251 173 116 98 74 22 660
Aleš Obreza Slovenia 11 284 1.1× 226 1.3× 110 0.9× 56 0.6× 67 0.9× 33 733
Leena Laitinen Finland 11 168 0.7× 79 0.5× 52 0.4× 72 0.7× 59 0.8× 15 553
Staffan Tavelin Sweden 13 293 1.2× 127 0.7× 60 0.5× 345 3.5× 57 0.8× 14 1.0k
Rebecca L. Edwards United States 10 297 1.2× 181 1.0× 58 0.5× 22 0.2× 51 0.7× 15 858
Hosnieh Tajerzadeh Iran 14 240 1.0× 61 0.4× 44 0.4× 102 1.0× 99 1.3× 36 792
Marwa A. Fouad Egypt 18 249 1.0× 209 1.2× 298 2.6× 52 0.5× 61 0.8× 81 901
Ankita Varshney India 12 624 2.5× 62 0.4× 96 0.8× 231 2.4× 30 0.4× 20 746
Edgar Nägele Germany 15 467 1.9× 255 1.5× 117 1.0× 57 0.6× 57 0.8× 19 715
Álvaro Cortés-Cabrera Spain 17 460 1.8× 38 0.2× 159 1.4× 106 1.1× 60 0.8× 39 736
Аndrey G. Pokrovsky Russia 18 411 1.6× 49 0.3× 292 2.5× 49 0.5× 26 0.4× 78 835

Countries citing papers authored by Shaoxia Yu

Since Specialization
Citations

This map shows the geographic impact of Shaoxia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoxia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoxia Yu more than expected).

Fields of papers citing papers by Shaoxia Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoxia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoxia Yu. The network helps show where Shaoxia Yu may publish in the future.

Co-authorship network of co-authors of Shaoxia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoxia Yu. A scholar is included among the top collaborators of Shaoxia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoxia Yu. Shaoxia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Qi, et al.. (2023). Enhanced strength-ductility synergy in NbC-reinforced FeMnCoCr high entropy alloy with heterostructure by adopting a novel process. Journal of Alloys and Compounds. 953. 170141–170141. 10 indexed citations
3.
Larkindale, Jane, Michelle Mellion, Jaya Goyal, et al.. (2023). Positive results from a first-in-human study supporting continued development of PGN-EDO51 for the treatment of duchenne muscular dystrophy (DMD). Journal of the Neurological Sciences. 455. 121117–121117. 1 indexed citations
4.
Mellion, Michelle, Jane Larkindale, Jaya Goyal, et al.. (2023). PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Duchenne Muscular Dystrophy (DMD): Results of a Phase 1 Study in Healthy Volunteers (P3-8.004). Neurology. 100(17_supplement_2). 5 indexed citations
5.
Yin, Feng, et al.. (2021). Quantitation of Ivosidenib in Human Plasma Via LC–MS/MS and its Application in Clinical Trials. Bioanalysis. 13(11). 875–889. 10 indexed citations
6.
Chen, Qi, Shaoxia Yu, Jiahui Wang, et al.. (2019). Severe Japanese encephalitis with multiple intracranial hemorrhages. Medicine. 98(41). e17453–e17453. 4 indexed citations
7.
Wolenski, Francis S., Andy Z. X. Zhu, Shaoxia Yu, et al.. (2017). Fasiglifam (TAK-875) alters bile acid homeostasis in rats and dogs: a potential cause of drug induced liver injury. Toxicological Sciences. 157(1). kfx018–kfx018. 43 indexed citations
8.
Liao, Mingxiang, Qing Zhu, Shaoxia Yu, et al.. (2017). Preclinical absorption, distribution, metabolism, excretion and pharmacokinetics of a novel selective inhibitor of breast cancer resistance protein (BCRP). Xenobiotica. 48(5). 467–477. 8 indexed citations
9.
10.
Wu, Jing‐Tao, et al.. (2012). A Simplified Approach For The Simultaneous Qualification of Bioanalytical Methods For Multiple Species At Late Discovery Stage. Bioanalysis. 4(9). 1065–1075. 1 indexed citations
11.
Crawford, Elizabeth A., et al.. (2011). Direct Analysis in Real Time Coupled with Dried Spot Sampling for Bioanalysis in a Drug-Discovery Setting. Bioanalysis. 3(11). 1217–1226. 42 indexed citations
12.
Yang, Johnny, Mark Milton, Shaoxia Yu, et al.. (2010). P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor. Drug Metabolism Letters. 4(4). 202–212. 43 indexed citations
13.
Li, Yu, Alex Bulychev, Lisa M. O’Brien, et al.. (2009). Abstract #2921: Pharmacokinetics and pharmacodynamics of a selective proteasome inhibitor MLN9708 in nonclinical species following either intravenous or oral administration. Cancer Research. 69. 2921–2921. 4 indexed citations
14.
15.
Yu, Shaoxia, et al.. (2005). On the change of fracture mechanism with test temperature. Engineering Fracture Mechanics. 73(3). 331–347. 13 indexed citations
16.
Jander, Georg, Susan R. Norris, Vijay Joshi, et al.. (2004). Application of a high‐throughput HPLC‐MS/MS assay to Arabidopsis mutant screening; evidence that threonine aldolase plays a role in seed nutritional quality. The Plant Journal. 39(3). 465–475. 109 indexed citations
17.
Yu, Shaoxia, Shelly Li, Hua Yang, et al.. (2004). A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery. Rapid Communications in Mass Spectrometry. 19(2). 250–254. 75 indexed citations
18.
Dong, Ying, et al.. (1999). Quararibea Metabolites. 4.1 Total Synthesis and Conformational Studies of (±)-Funebrine and (±)-Funebral. The Journal of Organic Chemistry. 64(8). 2657–2666. 39 indexed citations
19.
Cai, Xiong, Mukund S. Chorghade, Aberra Fura, et al.. (1998). Synthesis of CMI-977, a Potent 5-Lipoxygenase Inhibitor. Organic Process Research & Development. 3(1). 73–76. 23 indexed citations
20.
Yu, Shaoxia & Philip W. Le Quesne. (1995). metabolites. 3. Total synthesis of (±) - funebral, a rotationally restricted pyrrole alkaloid, using a novel Paal-Knorr reaction. Tetrahedron Letters. 36(35). 6205–6208. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleš Obreza Breakdown of academic impact, for papers by Leena Laitinen Breakdown of academic impact, for papers by Staffan Tavelin Breakdown of academic impact, for papers by Rebecca L. Edwards Breakdown of academic impact, for papers by Hosnieh Tajerzadeh Breakdown of academic impact, for papers by Marwa A. Fouad Breakdown of academic impact, for papers by Ankita Varshney Breakdown of academic impact, for papers by Edgar Nägele Breakdown of academic impact, for papers by Álvaro Cortés-Cabrera Breakdown of academic impact, for papers by Аndrey G. Pokrovsky
Rankless by CCL
2026